What is the long-term trend for Phathom Pharmaceuticals, Inc.'s debt issuance proceeds?

Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s debt issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $96.89M to $0.

What does debt issuance proceeds mean?

Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Phathom Pharmaceuticals, Inc. PHAT Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Opko HealthOPK

$8.49M+51.3%

AMP

Amphastar PharmaceuticalsAMPH

$172K-98.2%

OrganonOGN

$0-100%

AbbVieABBV

$7.99B+100%

AbbottABT

$19.86B+1,985,900%

Other financials

Income statement

See full

Revenue$58.3M+104%

Gross profit$46.3M+86.8%

Operating income-$15.5M+80.4%

Net income-$30.4M+67.8%

EPS (diluted)-$0.37+71.8%

Balance sheet

See full

Cash & equivalents$180.9M-14.8%

Total debt$166.3M-18.3%

Total equity-$337.0M+0.4%

Total assets$305.1M+3.7%

Cash flow

See full

Operating cash flow-$15.6M+81.6%

CapEx$61.0K+239%

Free cash flow-$15.7M+81.5%

Valuation

See full

Market cap$846.21M+13.4%

Enterprise value$831.61M+12.7%

P/S4.1×-5.0×

Profitability

See full

Gross margin84.9%-1.3pp

Operating margin-47.1%-21.9pp

Net margin-76.8%-34.5pp

FCF margin-47.7%-22.1pp

Returns & leverage

See full

Return on equity-147.9%—

Debt / equity5.6×—

Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s debt issuance proceeds?: Phathom Pharmaceuticals, Inc. (PHAT) reported debt issuance proceeds of $173.25M in Q1 2026.
What is the long-term trend for Phathom Pharmaceuticals, Inc.'s debt issuance proceeds?: Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s debt issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $96.89M to $0.
What does debt issuance proceeds mean?: Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.